|
KMID : 0614620090530010023
|
|
Korean Journal of Gastroenterology
2009 Volume.53 No. 1 p.23 ~ p.28
|
|
|
The Clinical Usefulness of Focally Enhanced Gastritis in Korean Patients with Crohn’s Disease
|
|
Hong Cheul-Ho
Sohn Chong-Il
Kim Dong-Hoon
Sohn Jin-Hee
Kim Min-Kyoung
Chae Seoung-Wan
Oh Suk-Joong
Park Dong-Il
Park Jung-Ho
Kim Hong-Ju
Cho Yong-Kyun
Kim Byung-Ik
Choi Woo-Hyuk
Jeon Woo-Kyu
Lee Kyoung-Bun
|
|
|
Abstract
|
|
|
Background/Aims: Focally enhanced gastritis (FEG) has been suggested as a specific diagnostic marker for patients with Crohn’s disease (CD). However, the usefulness of FEG for distinguishing CD from ulcerative colitis (UC) is uncertain and the incidence or prevalence of FEG for inflammatory bowel disease (IBD) patients in Korea has not been defined yet. In this study, we investigated the frequency of FEG and other gastric histological abnormalities in Korean patients with CD and UC.
Methods: We evaluated 37 patients with known CD, 43 patients with UC and 41 non-IBD control group; all underwent upper gastrointestinal endoscopy followed by biopsy from the antrum and the body. The pathology of the gastric biopsy specimens and the presence of Helicobacter pylori (H. pylori) were evaluated. FEG was characterized by a focal perifoveolar or periglandular inflammatory cell infiltrates.
Results: H. pylori positive gastritis was found in 10 of 37 (27.0%) of CD patients, in 16 of 43 (37.2%) of UC patients, and in 22 of 41 (53.7%) of non-IBD control group (p=0.054). In H. pylori-negative patients, FEG was found in 8 of 27 patients (29.6%) of CD patients, 6 of 27 (22.2%) patients with UC, and 2 of 9 (10.5%) of non-IBD control group (p=0.324).
Conclusions: In H. pylori-negative patients, there was no statistically significant difference in the occurrence of FEG among CD, UC and control groups in Korea.
|
|
|
KEYWORD
|
|
|
Crohn’s disease, Ulcerative colitis, Focally enhanced gastritis, Inflammatory bowel disease
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
   
|